ono 1078 has been researched along with ozagrel in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 13 (86.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, K; Hikasa, Y; Hori, K; Nishikawa, M; Shimoyama, T; Tanida, N; Yamada, K | 1 |
| Fujii, E; Nomoto, T | 1 |
| Ikeda, S; Kawasaki, A; Nambu, F; Okegawa, T; Omawari, N; Sawada, M; Yube, N | 1 |
| Makino, S | 1 |
| Adachi, M; Kobayashi, H; Misawa, M; Okazawa, A; Takahashi, T | 1 |
| Hashimoto, H; Hieda, N; Ito, T; Ito, Y; Ogawa, K; Okumura, K; Satake, T; Toki, Y; Torii, T | 1 |
| Hikasa, Y; Hori, K; Nishikawa, M; Shimoyama, T; Tanida, N | 1 |
| Iwama, T; Nagai, H; Sakurai, T; Yamaguchi, S | 1 |
| Aishita, H; Nakagawa, N; Obata, T; Okada, Y; Terawaki, T | 1 |
| Misawa, M; Sugiyama, Y | 1 |
| Iwahisa, Y; Kagoshima, M; Kawakami, Y; Terasawa, M; Tomomatsu, N; Yamaguchi, S | 1 |
| Iwahisa, Y; Kagoshima, M; Kawakami, Y; Matsuura, M; Terasawa, M; Tomomatsu, N; Yamaguchi, S | 1 |
| Fukuchi, Y; Ishii, S; Katayama, H; Nagase, T; Ouchi, Y; Shimizu, T | 1 |
| Asai, S; Kohno, S; Matsuo, N; Matsuse, H; Obase, Y; Shimoda, T | 1 |
| Asanuma, T; Ishibashi, Y; Katoh, H; Murakami, Y; Ohta, Y; Sano, K; Shimada, T; Shimizu, H; Takahashi, N | 1 |
1 trial(s) available for ono 1078 and ozagrel
| Article | Year |
|---|---|
Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma.
Topics: Administration, Oral; Adult; Anti-Asthmatic Agents; Antigens; Asthma; Benzoquinones; Blood Proteins; Bronchial Provocation Tests; Bronchoconstriction; Chromones; Cross-Over Studies; Eosinophil Granule Proteins; Female; Follow-Up Studies; Heptanoic Acids; Histamine; Humans; Leukotriene Antagonists; Male; Membrane Proteins; Methacrylates; Receptors, Leukotriene; Receptors, Thromboxane; Ribonucleases; Thromboxane B2; Thromboxane-A Synthase; Treatment Outcome | 1998 |
14 other study(ies) available for ono 1078 and ozagrel
| Article | Year |
|---|---|
Leukotriene C4 D4 antagonist markedly reduced inflammation in a rat model of inflammatory bowel disease.
Topics: Animals; Chromones; Colon; Inflammation; Inflammatory Bowel Diseases; Methacrylates; Phenylpropionates; Rats; SRS-A | 1992 |
[Changes in arachidonic acid-induced respiratory distress in streptozotocin-diabetic mice].
Topics: Animals; Arachidonic Acid; Chromones; Cyclooxygenase Inhibitors; Depression, Chemical; Diabetes Mellitus, Experimental; Male; Methacrylates; Mice; Respiration; SRS-A; Streptozocin; Thromboxane-A Synthase | 1992 |
Inhibition of endothelin-induced bronchoconstriction by OKY-046, a selective thromboxane A2 synthetase inhibitor, in guinea pigs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Atropine; Bridged Bicyclo Compounds; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Chromones; Endothelins; Fatty Acids, Monounsaturated; Guinea Pigs; Histamine; Indomethacin; Male; Methacrylates; Pyrilamine; Thromboxane B2; Thromboxane-A Synthase | 1991 |
[Eicosanoids in bronchial asthma].
Topics: Acrylates; Arachidonic Acids; Asthma; Benzoquinones; Bronchoalveolar Lavage Fluid; Chromones; Cyclooxygenase Inhibitors; Humans; Indomethacin; Leukocytes; Lipoxygenase Inhibitors; Lung; Macrophages; Methacrylates; Quinones; Thromboxane-A Synthase | 1990 |
[The effect of leukotriene C4/D4 receptor antagonist (ONO-1078) and thromboxane A2 synthetase inhibitor (OKY-046) on airway hyperresponsiveness induced by ozone exposure in guinea pigs].
Topics: Acrylates; Administration, Inhalation; Animals; Bronchi; Bronchoalveolar Lavage Fluid; Chromones; Guinea Pigs; Methacholine Chloride; Methacholine Compounds; Methacrylates; Muscle Contraction; Ozone; Receptors, Immunologic; Receptors, Leukotriene; Thromboxane A2 | 1990 |
Effects of a new thromboxane A2-antagonist (ONO-3708) and a new leukotriene-antagonist (ONO-1078) on thromboxane A2 analogue-, leukotriene C4-, and D4-induced regional myocardial blood flow reduction.
Topics: Animals; Blood Flow Velocity; Chromones; Coronary Circulation; Coronary Disease; Dogs; Male; Methacrylates; SRS-A; Thromboxane A2; Thromboxane-A Synthase | 1988 |
Effect of leukotriene C4D4 antagonist on colonic damage induced by intracolonic administration of trinitrobenzene sulfonic acid in rats.
Topics: Animals; Chromones; Colon; Disease Models, Animal; Eicosanoids; Female; Inflammatory Bowel Diseases; Leukotriene C4; Leukotriene D4; Methacrylates; Peroxidase; Phenylpropionates; Rats; Rats, Sprague-Dawley; SRS-A; Thromboxane-A Synthase; Trinitrobenzenesulfonic Acid | 1995 |
Pharmacological studies of platelet-activating factor (PAF)-induced augmentation of response to histamine in guinea-pigs.
Topics: Animals; Benzoquinones; Bridged Bicyclo Compounds; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Capillary Permeability; Chromones; Drug Interactions; Fatty Acids, Monounsaturated; Guinea Pigs; Histamine; Indomethacin; Leukocyte Count; Leukotriene Antagonists; Lipoxygenase Inhibitors; Male; Methacrylates; Phospholipid Ethers; Platelet Activating Factor; Pressure; Respiratory Physiological Phenomena; Respiratory System; Thromboxane A2 | 1994 |
Inhibitory effect of a peptide leukotriene antagonist ONO-1078 on LTD4- and antigen-induced thromboxane B2 production in guinea pig lungs.
Topics: Animals; Antigens; Bordetella pertussis; Chromones; Dose-Response Relationship, Drug; Guinea Pigs; Indomethacin; Kinetics; Lung; Male; Methacrylates; Ovalbumin; SRS-A; Thromboxane B2; Thromboxane-A Synthase | 1993 |
An airway hyperresponsiveness model in rat allergic asthma.
Topics: Acetylcholine; Animals; Ascaris; Asthma; Bronchial Hyperreactivity; Capillary Permeability; Chromones; Depression, Chemical; Dinitrophenols; Disease Models, Animal; Male; Methacrylates; Phospholipid Ethers; Platelet Activating Factor; Rats; Rats, Wistar; SRS-A; Thromboxane-A Synthase; Tissue Extracts | 1993 |
Effects of Y-24180, a long-acting and potent antagonist to platelet-activating factor, on immediate asthmatic response in guinea pigs.
Topics: Animals; Anti-Asthmatic Agents; Asthma; Azepines; Benzoquinones; Bronchodilator Agents; Chromones; Drug Interactions; Drug Therapy, Combination; Guinea Pigs; Heptanoic Acids; Male; Methacrylates; Platelet Activating Factor; Theophylline; Triazoles | 1997 |
Suppressive effects of Y-24180, a receptor antagonist to platelet activating factor (PAF), on antigen-induced asthmatic responses in guinea pigs.
Topics: Administration, Oral; Aerosols; Animals; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Azepines; Benzoquinones; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Bronchodilator Agents; Chromones; Enzyme Inhibitors; Guinea Pigs; Heptanoic Acids; Histamine Antagonists; Leukotriene Antagonists; Male; Methacrylates; Ovalbumin; Platelet Membrane Glycoproteins; Pyrilamine; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Serine Proteinase Inhibitors; Signal Transduction; Theophylline; Thromboxane-A Synthase; Triazoles | 1997 |
Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes.
Topics: Animals; Azepines; Bronchi; Bronchial Hyperreactivity; Chromones; Indoles; Indomethacin; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Lung; Methacrylates; Mice; Mice, Transgenic; Phenylpropionates; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Leukotriene B4; Thromboxanes; Triazoles | 1997 |
Beneficial effect of combination therapy with ozagrel and pranlukast in exercise-induced asthma demonstrated by krypton-81 m ventilation scintigraphy--a case report.
Topics: Asthma, Exercise-Induced; Chromones; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Krypton Radioisotopes; Leukotriene Antagonists; Methacrylates; Middle Aged; Radionuclide Imaging; Respiratory Function Tests; Severity of Illness Index; Treatment Outcome | 2000 |